Biotech consolidation picks up with $6.4bn deal
October 29, 2003The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …
Foundation status reform not most important, say trusts
October 29, 2003The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …
Novartis buys Pfizer incontinence drug
October 29, 2003Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …
Look closer – The importance of local opinion leaders
October 29, 2003Sales and Marketing key opinion leaders
There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Roche survey shows cancer postcode prescribing continues
October 29, 2003A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …
Limited lifting of NICE ‘ban’ on Tamiflu
October 29, 2003Sales and Marketing
Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …
The new GP contract : incentives for pharma too
October 29, 2003GP contract, NHS, healthcare
As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …
Betaferon and Avonex in head-to-head MS trial
October 29, 2003Research and Development, Sales and Marketing
Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
Aventis awards ClinPhone preferred supplier status
October 29, 2003Research and Development
Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …
Do doctors really use the Internet?
October 29, 2003Sales and Marketing doctors, internet
Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …
Zyprexa approved for bipolar disorder
October 29, 2003Sales and Marketing
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …
New HRT study shows doubling of cancer risk
October 29, 2003Research and Development
A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …
Retaining the talent you recruit
October 29, 2003Business Services recruitment, strategy
The vast majority of people who want to work in the pharma industry have high ideals and wish to be …
Merck expands into US proteomics
October 29, 2003Research and Development
Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …
Shire cuts back ahead of US expansion
October 29, 2003Sales and Marketing
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …
Latest content
FibroFind appoints Lee Borthwick as CEO
